GlassScriptPhysician profile
Kristyn Beck
NPI 1780927160
$1,044.62
in general payments reported to CMS, 2019-2025
13 companies · $193 in 2025
The $193 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $187 · 2021: $99.65 · 2022: $75.04 · 2023: $114 · 2024: $199 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366 · Education: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.81 |
| Education | $140.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $414.79 | 2019-2024 | Rinvoq |
| Janssen Biotech, INC. | $140.99 | 2024-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $117.38 | 2024-2025 | |
| Galderma Laboratories, L.P. | $87.40 | 2019-2025 | Aklief |
| Genzyme Corporation | $63.15 | 2022-2025 | |
| Aclaris Therapeutics, INC. | $58.48 | 2019 | |
| Pfizer INC. | $43.55 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $27.85 | 2024-2025 | Dupixent |
| Celgene Corporation | $21.01 | 2019 | |
| Ucb, INC. | $19.06 | 2019 | |
| Leo Pharma INC. | $18.69 | 2024 | Adbry |
| Arcutis Biotherapeutics, INC. | $18.22 | 2023 | |
| Allergan, INC. | $14.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristyn Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.